{"gene":"SMPD2","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1998,"finding":"The cloned murine and human SMPD2 (then called nSMase) was identified as a ubiquitously expressed integral membrane protein with Mg2+-dependent neutral sphingomyelinase activity at the plasma membrane. Stable overexpression in U937 and HEK cells confirmed sphingomyelinase activity, though TNF-α stimulation produced only modest ceramide elevation without activating JNK, NFκB, or ERK1 pathways in these overexpressor lines.","method":"Molecular cloning, stable overexpression, in vitro SMase activity assays, signal transduction assays (JNK, NFκB, PARP cleavage)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — original cloning with in vitro activity characterization and functional overexpression, foundational paper","pmids":["9520418"],"is_preprint":false},{"year":1999,"finding":"The originally cloned putative nSMase (SMPD2/nSMase1) was shown to function primarily as a lyso-platelet-activating factor phospholipase C (lyso-PAF-PLC) rather than as a sphingomyelinase in cells. Overexpression did not alter ceramide or sphingomyelin metabolism but caused accumulation of 1-O-alkyl-sn-glycerol, and in vitro assays demonstrated lyso-PAF and lyso-PC are substrates.","method":"Radiolabeling with [3H]palmitic acid/[3H]hexadecanol, in vitro substrate assays, immunoprecipitation of enzyme activity, metabolic labeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with substrate specificity testing and cellular metabolic tracing, rigorous functional reassignment","pmids":["10608884"],"is_preprint":false},{"year":2000,"finding":"The yeast SMPD2 ortholog ISC1 (YER019w) was identified as an inositol phosphosphingolipid phospholipase C (IPS-PLC). Overexpression greatly increased neutral SMase activity in a phosphatidylserine-dependent manner; ISC1 deletion eliminated neutral SMase and IPS-PLC activities and caused accumulation of complex sphingolipids, establishing ISC1 as the first enzyme in complex sphingolipid catabolism in yeast.","method":"Overexpression, gene deletion, in vitro enzyme activity assays, [3H]dihydrosphingosine metabolic labeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — genetic loss-of-function combined with in vitro activity assays and metabolic labeling, foundational paper with 134 citations","pmids":["11006294"],"is_preprint":false},{"year":2002,"finding":"Structural determinants for ISC1 activation by anionic phospholipids were defined. The second transmembrane domain (TMII) and C-terminus are required and sufficient for binding phosphatidylserine (PS), cardiolipin (CL), and phosphatidylglycerol (PG). Positively charged residues at the C-terminus mediate PS/CL/PG interaction and enzyme activation. Reconstitution experiments showed that the N-terminal catalytic domain and C-terminal region must interact for enzymatic activity, suggesting PS pulls the catalytic domain to the membrane.","method":"Site-directed mutagenesis, deletion mutants, lipid-protein overlay assays, GFP fusion heterologous expression, enzymatic reconstitution from separate fragments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods including mutagenesis, lipid binding assays, and reconstitution","pmids":["12244059"],"is_preprint":false},{"year":2002,"finding":"ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance in yeast. Deletion of ISC1 severely impaired growth on NaCl/LiCl, reduced Na+/Li+-stimulated ENA1 (cation-extrusion ATPase) expression, and decreased Ena1p-dependent ion extrusion, placing ISC1-dependent sphingolipid hydrolysis as an early event in salt-induced ENA1 signaling.","method":"Gene deletion, growth assays, ENA1-lacZ reporter assays, ion extrusion measurements","journal":"European journal of biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with reporter assays, single lab","pmids":["12180980"],"is_preprint":false},{"year":2003,"finding":"Catalytic residues of ISC1 were defined by site-directed mutagenesis: E100, N233, and H334 are essential for catalysis. A P-loop-like domain (G162–S169) was identified; D163A and K168A completely abolished activity, while G162A, G167A, and S169A reduced Vmax without affecting Km. The P-loop-like domain is involved in Mg2+ binding and optimal catalytic efficiency, potentially interacting with the PS activator.","method":"Site-directed mutagenesis, in vitro enzyme kinetics (Km, Vmax, Mg2+ Ka), phosphatidylserine binding assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — systematic active-site mutagenesis with kinetic characterization","pmids":["12820895"],"is_preprint":false},{"year":2003,"finding":"Mouse nSMase2 (SMPD2) was biochemically characterized as a bona fide neutral sphingomyelinase. The enzyme requires Mg2+, is activated by phosphatidylserine, and is inhibited by GW4869. Overexpression in MCF7 cells decreased sphingomyelin levels by 40% and increased ceramide by 60%. nSMase2 overexpression reduced cell growth by 30–40%, and TNF-α induced ~50% activation of nSMase2 in overexpressing MCF7 cells.","method":"Heterologous expression in isc1Δ yeast, in vitro activity assays, SM/ceramide mass measurement in MCF7 cells, [3H] labeling, cell growth assays, TNF-α stimulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution in isc1Δ yeast plus cellular SM/ceramide mass measurements with multiple orthogonal approaches","pmids":["12566438"],"is_preprint":false},{"year":2004,"finding":"Endogenous nSMase2 (SMPD2) functions as a growth suppressor in MCF7 cells. At confluence, nSMase2 mRNA was upregulated ~5-fold, neutral SMase activity increased 119%, and ceramide (particularly very long chain C24:1 and C24:0 species) was elevated. siRNA knockdown of nSMase2 increased S-phase cells by 59%, prevented hypophosphorylation of retinoblastoma protein, and blocked p21(WAF1) induction. nSMase2 also redistributed from cytoplasm to plasma membrane upon confluence.","method":"siRNA knockdown, cell cycle analysis (flow cytometry), ceramide mass measurement, western blotting (Rb phosphorylation, p21), immunofluorescence localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with multiple downstream readouts (cell cycle, ceramide species, Rb/p21), confirmed localization change","pmids":["15051724"],"is_preprint":false},{"year":2004,"finding":"Expression of FLAG-tagged mouse nSMase2 (SMPD2) in primary rat hepatocytes via adenoviral gene transfer increased cellular ceramide levels and potentiated IL-1β-induced JNK phosphorylation 1.5–2-fold. This potentiation was mediated by a PP2A family phosphatase, possibly by modulating IRAK phosphorylation. nSMase2 localized to the plasma membrane in HepG2 cells.","method":"Adenovirus-mediated gene transfer, in vitro SMase activity assay, ceramide measurement, JNK phosphorylation assay, phosphatase inhibitor studies, immunofluorescence","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with ceramide and JNK readouts, PP2A pathway placed mechanistically, single lab","pmids":["15059969"],"is_preprint":false},{"year":2007,"finding":"Yeast Isc1p (SMPD2 ortholog) localizes to the outer mitochondrial membrane as an integral membrane protein in the post-diauxic phase. Endogenous Isc1p activity was enriched in highly purified mitochondria. Mitochondria from isc1Δ cells showed 93% loss of alpha-hydroxylated phytoceramide. Functionally, isc1Δ exhibited higher respiratory-deficient cell rates at high temperature and sensitivity to hydrogen peroxide, establishing mitochondrial ceramide generation by Isc1p as important for mitochondrial function.","method":"Subcellular fractionation, western blotting of mitochondrial fractions, LC/MS sphingolipid profiling, respiratory competence assays, oxidative stress sensitivity assays","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 2 — direct localization by fractionation combined with lipidomics and functional phenotypes, multiple orthogonal methods","pmids":["17880915"],"is_preprint":false},{"year":2009,"finding":"ISC1 (SMPD2 ortholog) regulates the G2/M checkpoint in yeast. isc1Δ cells treated with hydroxyurea (HU) showed G2/M block associated with elevated Cdc28-Tyr19 phosphorylation. Sustained Swe1p (the kinase phosphorylating Cdc28-Tyr19) levels in isc1Δ cells after HU were responsible; deletion of SWE1 in isc1Δ overcame the G2/M block. A Cdc28-Y19F mutant also rescued isc1Δ from G2/M arrest, placing Isc1p as an upstream regulator of Swe1p stability.","method":"Flow cytometry cell cycle analysis, western blotting (Cdc28-pTyr19, Swe1p), double-mutant genetic epistasis (isc1Δ/swe1Δ, isc1Δ/cdc28-Y19F), HU sensitivity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double mutants and phosphorylation site mutants, multiple readouts","pmids":["19158081"],"is_preprint":false},{"year":2009,"finding":"Isc1p (SMPD2 ortholog) in yeast mitochondria is required for metabolic adaptation during the diauxic shift. isc1Δ cells showed defective aerobic respiration despite intact intrinsic mitochondrial functions (normal mtDNA, O2 consumption, membrane potential). Microarray analysis revealed failure to upregulate genes for nonfermentable carbon metabolism. The mitochondrial requirement for this nuclear gene induction overlapped with Adr1p-, Snf1p-, and Cat8p-dependent genes, but did not activate the retrograde response.","method":"Microarray gene expression, respiratory assays, mitochondrial membrane potential measurement, mtDNA analysis, genetic analysis with petite cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide expression + mitochondrial function assays, single lab","pmids":["19179331"],"is_preprint":false},{"year":2010,"finding":"nSMase2 (SMPD2) was identified as a critical mediator of Withanolide D-induced apoptosis in leukemia cells. siRNA knockdown of nSMase2 and the nSMase inhibitor GW4869 significantly reduced ceramide generation, MKK4 and MKK3/6 phosphorylation, and apoptosis in K562 and MOLT-4 cells, placing SMPD2 upstream of the JNK/p38 MAPK cascade in this apoptotic pathway.","method":"siRNA knockdown of nSMase2, pharmacological inhibition (GW4869), ceramide measurement, kinase phosphorylation assays (JNK, p38, MKK4, MKK3/6), apoptosis assays","journal":"Molecular cancer","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA loss-of-function with multiple downstream kinase readouts, single lab","pmids":["20836852"],"is_preprint":false},{"year":2010,"finding":"nSMase2 (SMPD2) was established as the central in vivo mediator of cigarette smoke-induced ceramide generation and apoptosis in lung. Heterozygous nSMase2 mice showed significantly decreased ceramide after CS exposure; aSMase knockout mice maintained wild-type ceramide levels. Anti-nSMase2 siRNA abrogated CS-induced ceramide elevation and TUNEL-positive cells. N-acetyl cysteine treatment also abrogated these effects, linking oxidative stress to nSMase2 activation.","method":"nSMase2 heterozygous mouse model, aSMase knockout mice, in vivo siRNA, ceramide measurement in lung tissue, TUNEL assay, N-acetyl cysteine treatment","journal":"American journal of respiratory cell and molecular biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic models (heterozygous KO, siRNA) with multiple controls and orthogonal endpoints","pmids":["20448054"],"is_preprint":false},{"year":2011,"finding":"ISC1 (SMPD2 ortholog) interacts with the DNA integrity checkpoint pathway to control cell morphology. isc1Δ cells under HU treatment exhibited morphological aberrations, cell-wall defects, and defects in actin depolymerization. Genetic analysis showed synthetic interactions: isc1Δ combined with mrc1Δ, tof1Δ, or csm3Δ enhanced morphological defects, while isc1Δ/rad9Δ reduced them. Swe1 and Cdk1 were identified as key mediators, and Rad53 dosage partially influenced isc1Δ morphology.","method":"Genetic epistasis (double mutants), flow cytometry, morphological analysis, actin staining, checkpoint gene deletions","journal":"Genetics","confidence":"Medium","confidence_rationale":"Tier 2 — systematic genetic epistasis across multiple checkpoint genes, single lab","pmids":["21840863"],"is_preprint":false},{"year":2014,"finding":"SMPD2 (nSMase1 in zebrafish nomenclature) is phosphorylated by JNK at Ser-270, which activates the enzyme to generate ceramide and induce apoptosis. S270A substitution blocked phosphorylation and activation; S270E (phosphomimetic) mimicked activation. JNK inhibitor SP600125 blocked nSMase1 phosphorylation and ceramide generation. Multiple stresses (heat shock, UV, H2O2, anti-Fas) induced this phosphorylation. MAPK8/9 or SMPD2 RNAi knockdown in human Jurkat T cells decreased ceramide and stress/cytokine-induced apoptosis.","method":"Site-directed mutagenesis (S270A, S270E), JNK inhibitor treatment, RNAi knockdown in zebrafish and human Jurkat cells, ceramide measurement, apoptosis assays, phosphorylation assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1 — phosphorylation site mutagenesis with phosphomimetic + loss-of-function in two cell systems, multiple stress stimuli tested","pmids":["25168245"],"is_preprint":false},{"year":2020,"finding":"In yeast, ISC1 (SMPD2 ortholog) is positioned within the spindle assembly checkpoint (SAC) pathway. Deletion of SAC genes (BUB1, MAD1, BIM1, KAR3) phenocopied ISC1 deletion, and spindle checkpoint genes act upstream of Isc1. ISC1 deletion mutants were sensitive to benomyl (SAC defect indicator) and failed spindle elongation in HU-treated cells (similar to bub1Δ). PP2A-Cdc55 ceramide-activated phosphatase acts downstream of Isc1p, coupling the spindle checkpoint to CDC55-mediated nuclear functions.","method":"Synthetic lethality analysis, gene deletion, benomyl sensitivity assays, spindle elongation imaging, epistasis with cdc55, concordance analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — synthetic lethality combined with epistasis and functional assays, single lab","pmids":["32205408"],"is_preprint":false},{"year":2022,"finding":"In yeast, Isc1 (SMPD2 ortholog) and the PG-specific phospholipase Pgc1 functionally cooperate to regulate mitochondrial function. Deletion of PGC1 rescued the mitochondrial dysfunction (reduced PE levels and cytochrome c oxidase activity) in isc1Δ cells. The Pgc1 substrate PG inhibited Isc1 activity in vitro. Products of Isc1-mediated hydrolysis partially inhibited Pgc1 activity, establishing a cross-inhibitory feedback loop linking sphingolipid and phospholipid metabolism for mitochondrial homeostasis.","method":"Double-mutant genetic rescue (pgc1Δ isc1Δ), in vitro enzyme activity assays with PG substrate/inhibitor, PE and cytochrome c oxidase activity measurements","journal":"Microbiology spectrum","confidence":"Medium","confidence_rationale":"Tier 2 — genetic rescue combined with in vitro enzyme assays, single lab","pmids":["36377885"],"is_preprint":false},{"year":2025,"finding":"Overexpression of Isc1 (SMPD2 ortholog) in chronologically aged yeast prevented dramatic mitochondrial morphological changes (large rounded morphology, decreased outer membrane/matrix co-localization, decreased membrane potential) that normally occur during aging. Similar sphingolipid-dependent mitochondrial morphological transitions were observed following acute oxidative stress, suggesting SMPD2-ortholog activity promotes adaptive mitochondrial remodeling.","method":"Isc1 overexpression, confocal microscopy of mitochondrial morphology, pharmacological and genetic perturbation of sphingolipid biosynthesis, mitochondrial membrane potential measurements","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — preprint, single lab, morphological readout without full mechanistic dissection","pmids":[],"is_preprint":true}],"current_model":"SMPD2 (neutral sphingomyelinase 2/nSMase2) is a Mg2+-dependent integral membrane neutral sphingomyelinase that hydrolyzes sphingomyelin to ceramide and phosphocholine at the plasma membrane; its catalytic activity requires conserved residues E100, N233, H334, and a P-loop-like domain (D163, K168) involved in Mg2+ coordination, while activation depends on anionic phospholipids (phosphatidylserine, cardiolipin) binding to the second transmembrane domain and C-terminus; in cells, SMPD2 is activated by TNF-α, JNK-mediated phosphorylation at Ser-270, and oxidative/genotoxic stress to generate ceramide that drives G0/G1 arrest (via Rb hypophosphorylation and p21 induction), apoptosis (via JNK/p38 MAPK cascades), and — through its yeast ortholog Isc1p — regulates the G2/M and spindle checkpoints via Swe1p stability and PP2A-Cdc55 ceramide-activated phosphatase, and localizes to mitochondria to support mitochondrial lipid homeostasis and metabolic adaptation."},"narrative":{"teleology":[{"year":1998,"claim":"Molecular cloning established SMPD2 as a ubiquitously expressed, Mg²⁺-dependent integral membrane neutral sphingomyelinase, resolving the molecular identity of a long-sought mammalian nSMase activity.","evidence":"Cloning and stable overexpression in U937 and HEK cells with in vitro SMase activity assays","pmids":["9520418"],"confidence":"High","gaps":["Overexpression did not robustly activate JNK/NFκB, leaving signaling function uncertain","Endogenous loss-of-function data were lacking"]},{"year":1999,"claim":"A functional reassignment revealed that overexpressed SMPD2 acts primarily as a lyso-PAF phospholipase C in cellular contexts, raising questions about whether sphingomyelin is its physiological substrate in vivo.","evidence":"Metabolic labeling with [³H]palmitic acid and in vitro substrate specificity assays in overexpressing cells","pmids":["10608884"],"confidence":"High","gaps":["Controversy about primary substrate identity not fully resolved for endogenous enzyme","Lyso-PAF PLC activity not tested in all relevant cell types"]},{"year":2000,"claim":"Identification of the yeast ortholog ISC1 as an inositol phosphosphingolipid phospholipase C that accounts for all neutral SMase activity in yeast provided genetic tractability and confirmed sphingolipid hydrolysis as the conserved core function.","evidence":"Gene deletion eliminating neutral SMase/IPS-PLC activity, metabolic labeling showing sphingolipid accumulation in isc1Δ","pmids":["11006294"],"confidence":"High","gaps":["Yeast sphingolipid substrates differ from mammalian sphingomyelin","Whether mammalian SMPD2 performs equivalent in vivo sphingomyelin hydrolysis remained unclear"]},{"year":2002,"claim":"Structural dissection of ISC1 revealed that anionic phospholipid activation requires the second transmembrane domain and C-terminal positively charged residues, and that the N-terminal catalytic domain must be recruited to the membrane by PS for activity.","evidence":"Site-directed mutagenesis, lipid-protein overlay assays, reconstitution from separate enzyme fragments","pmids":["12244059"],"confidence":"High","gaps":["No crystal structure to confirm membrane-recruitment model","Mammalian SMPD2 C-terminal domain not independently tested"]},{"year":2003,"claim":"Systematic active-site mutagenesis identified essential catalytic residues (E100, N233, H334) and a P-loop-like domain (D163, K168) required for Mg²⁺ coordination, defining the catalytic mechanism.","evidence":"Site-directed mutagenesis of ISC1 with full enzyme kinetics (Km, Vmax, Mg²⁺ Ka)","pmids":["12820895"],"confidence":"High","gaps":["No structural data confirming Mg²⁺ coordination geometry","Applicability of all residue assignments to mammalian SMPD2 inferred by homology"]},{"year":2003,"claim":"Biochemical characterization of mouse nSMase2 confirmed it as a bona fide neutral sphingomyelinase that reduces cellular sphingomyelin, elevates ceramide, suppresses growth, and is activated by TNF-α, resolving the substrate identity debate for the mammalian enzyme.","evidence":"Expression in isc1Δ yeast, SM/ceramide mass measurements in MCF7 cells, TNF-α stimulation","pmids":["12566438"],"confidence":"High","gaps":["Endogenous loss-of-function data for mammalian SMPD2 not yet available","Relative contribution of lyso-PAF PLC vs. SMase activity in vivo still unresolved"]},{"year":2004,"claim":"Endogenous SMPD2 was shown to function as a growth suppressor that generates C24 ceramide species at confluence, enforcing G0/G1 arrest via Rb hypophosphorylation and p21 induction, and redistributes to the plasma membrane upon cell–cell contact.","evidence":"siRNA knockdown in MCF7 cells with flow cytometry, ceramide species analysis, Rb/p21 western blotting, immunofluorescence","pmids":["15051724"],"confidence":"High","gaps":["Mechanism of confluence-triggered SMPD2 upregulation unknown","Direct link between C24 ceramide species and Rb/p21 pathway not established"]},{"year":2007,"claim":"Isc1p was found to localize to the outer mitochondrial membrane during the post-diauxic phase, where it generates α-hydroxylated phytoceramide essential for mitochondrial function under stress, establishing a mitochondrial role for this enzyme family.","evidence":"Subcellular fractionation of purified mitochondria, LC/MS sphingolipidomics, respiratory competence and oxidative stress assays in isc1Δ","pmids":["17880915"],"confidence":"High","gaps":["Whether mammalian SMPD2 also translocates to mitochondria is unknown","Mechanism of Isc1p mitochondrial targeting not defined"]},{"year":2009,"claim":"ISC1 was positioned as a regulator of the G2/M checkpoint through control of Swe1p stability and Cdc28-Tyr19 phosphorylation, and as necessary for metabolic gene reprogramming during the diauxic shift, broadening its role beyond lipid metabolism to cell cycle and metabolic adaptation.","evidence":"Double-mutant epistasis (isc1Δ/swe1Δ, Cdc28-Y19F), flow cytometry, microarray gene expression profiling","pmids":["19158081","19179331"],"confidence":"High","gaps":["Signaling intermediates between ceramide and Swe1p stabilization not identified","Transcriptional regulation mechanism downstream of mitochondrial ceramide unclear"]},{"year":2010,"claim":"SMPD2 was validated as the central in vivo mediator of stress-induced ceramide generation and apoptosis, shown in cigarette smoke-exposed mouse lung (heterozygous KO) and in leukemia cells where it acts upstream of MKK4–JNK/p38 MAPK cascades.","evidence":"nSMase2 heterozygous mice, in vivo siRNA, aSMase KO controls, siRNA and GW4869 in leukemia cell lines with kinase phosphorylation readouts","pmids":["20448054","20836852"],"confidence":"High","gaps":["Full knockout mouse phenotype not reported","Tissue-specific contributions of SMPD2 vs. SMPD3 not delineated"]},{"year":2014,"claim":"JNK-mediated phosphorylation at Ser-270 was identified as the activating post-translational modification of SMPD2, explaining how diverse stresses converge on ceramide generation and apoptosis.","evidence":"S270A/S270E mutagenesis, JNK inhibitor, RNAi in zebrafish and Jurkat cells, multiple stress stimuli","pmids":["25168245"],"confidence":"High","gaps":["Structural basis for how S270 phosphorylation increases catalytic activity unknown","Other potential phosphorylation sites not systematically mapped"]},{"year":2020,"claim":"ISC1 was integrated into the spindle assembly checkpoint pathway, with SAC genes acting upstream and PP2A-Cdc55 acting as a ceramide-activated phosphatase downstream, linking sphingolipid signaling to mitotic fidelity.","evidence":"Synthetic lethality with SAC gene deletions, benomyl sensitivity, epistasis with CDC55","pmids":["32205408"],"confidence":"Medium","gaps":["Direct biochemical activation of PP2A-Cdc55 by ceramide species not shown","Mammalian counterpart of this checkpoint connection not tested"]},{"year":2022,"claim":"A cross-inhibitory feedback loop between Isc1 and the phospholipase Pgc1 was discovered, integrating sphingolipid and phospholipid metabolism for mitochondrial homeostasis.","evidence":"Double-mutant rescue (pgc1Δ isc1Δ), in vitro enzyme inhibition assays, PE and cytochrome c oxidase measurements","pmids":["36377885"],"confidence":"Medium","gaps":["Quantitative flux through this feedback loop in vivo not measured","Mammalian equivalent of Pgc1 counterpart not identified"]},{"year":null,"claim":"Key unresolved questions include the structural basis of SMPD2 catalysis and membrane association, the in vivo partitioning between SMase and lyso-PAF PLC activities, whether mammalian SMPD2 translocates to mitochondria, and the full phenotype of a complete SMPD2 knockout mouse.","evidence":"","pmids":[],"confidence":"High","gaps":["No crystal or cryo-EM structure available","Complete SMPD2 knockout mouse not characterized","Relative physiological importance of lyso-PAF PLC vs. SMase activity unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,2,5,6]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,7,8]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12,13,15]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7,10,16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[8,12,15]}],"complexes":[],"partners":["MAPK8","MAPK9","PP2A"],"other_free_text":[]},"mechanistic_narrative":"SMPD2 encodes a Mg²⁺-dependent neutral sphingomyelinase that hydrolyzes sphingomyelin to ceramide and phosphocholine, functioning as a stress-responsive ceramide generator that couples lipid signaling to cell cycle arrest, apoptosis, and mitochondrial homeostasis. Catalysis requires conserved residues E100, N233, H334, and a P-loop-like domain (D163, K168) involved in Mg²⁺ coordination, and the enzyme is activated by anionic phospholipids (phosphatidylserine, cardiolipin) binding to its second transmembrane domain and C-terminus [PMID:12820895, PMID:12244059]. JNK-mediated phosphorylation at Ser-270 activates SMPD2 under diverse stresses (UV, oxidative stress, TNF-α, anti-Fas), and the resulting ceramide drives G0/G1 arrest through Rb hypophosphorylation and p21 induction, or apoptosis via JNK/p38 MAPK cascades [PMID:25168245, PMID:15051724, PMID:20836852]. Studies of the yeast ortholog Isc1p further establish roles in mitochondrial ceramide generation critical for respiratory adaptation, mitochondrial morphology maintenance, and integration with checkpoint signaling through Swe1p stability and PP2A-Cdc55 [PMID:17880915, PMID:19158081, PMID:32205408]."},"prefetch_data":{"uniprot":{"accession":"O60906","full_name":"Sphingomyelin phosphodiesterase 2","aliases":["Lyso-platelet-activating factor-phospholipase C","Lyso-PAF-PLC","Neutral sphingomyelinase","N-SMase","nSMase","nSMase1"],"length_aa":423,"mass_kda":47.6,"function":"Catalyzes, at least in vitro, the hydrolysis of sphingomyelin to form ceramide and phosphocholine (PubMed:10608884). Also hydrolyzes 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine (lyso-platelet-activating factor) in vivo (PubMed:10608884). Also acts on 1-acyl-2-lyso-sn-glycero-3-phosphocholine (lyso-PC) and sphingosylphosphocholine (PubMed:10608884, PubMed:14741383)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/O60906/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SMPD2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SMPD2","total_profiled":1310},"omim":[{"mim_id":"610457","title":"SPHINGOMYELIN PHOSPHODIESTERASE 4, NEUTRAL MEMBRANE; SMPD4","url":"https://www.omim.org/entry/610457"},{"mim_id":"605777","title":"SPHINGOMYELIN PHOSPHODIESTERASE 3, NEUTRAL MEMBRANE; SMPD3","url":"https://www.omim.org/entry/605777"},{"mim_id":"604709","title":"T-CELL LYMPHOMA INVASION AND METASTASIS 2; TIAM2","url":"https://www.omim.org/entry/604709"},{"mim_id":"603498","title":"SPHINGOMYELIN PHOSPHODIESTERASE 2, NEUTRAL MEMBRANE; SMPD2","url":"https://www.omim.org/entry/603498"},{"mim_id":"104760","title":"AMYLOID BETA A4 PRECURSOR PROTEIN; APP","url":"https://www.omim.org/entry/104760"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":49.6}],"url":"https://www.proteinatlas.org/search/SMPD2"},"hgnc":{"alias_symbol":["nSMase","ISC1"],"prev_symbol":[]},"alphafold":{"accession":"O60906","domains":[{"cath_id":"3.60.10.10","chopping":"7-284","consensus_level":"high","plddt":95.7936,"start":7,"end":284},{"cath_id":"1.10.287","chopping":"299-401","consensus_level":"high","plddt":92.2544,"start":299,"end":401}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60906","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60906-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60906-F1-predicted_aligned_error_v6.png","plddt_mean":89.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SMPD2","jax_strain_url":"https://www.jax.org/strain/search?query=SMPD2"},"sequence":{"accession":"O60906","fasta_url":"https://rest.uniprot.org/uniprotkb/O60906.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60906/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60906"}},"corpus_meta":[{"pmid":"11006294","id":"PMC_11006294","title":"Identification of ISC1 (YER019w) as inositol phosphosphingolipid phospholipase C in Saccharomyces cerevisiae.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11006294","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20378533","id":"PMC_20378533","title":"Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20378533","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15059969","id":"PMC_15059969","title":"Expression of neutral sphingomyelinase-2 (NSMase-2) in primary rat hepatocytes modulates IL-beta-induced JNK activation.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15059969","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17880915","id":"PMC_17880915","title":"Isc1 regulates sphingolipid metabolism in yeast mitochondria.","date":"2007","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/17880915","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19179331","id":"PMC_19179331","title":"ISC1-dependent metabolic adaptation reveals an indispensable role for mitochondria in induction of nuclear genes during the diauxic shift in Saccharomyces cerevisiae.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19179331","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18305313","id":"PMC_18305313","title":"Thematic review series: sphingolipids. ISC1 (inositol phosphosphingolipid-phospholipase C), the yeast homologue of neutral sphingomyelinases.","date":"2008","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/18305313","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16691498","id":"PMC_16691498","title":"Lactosylceramide is required in apoptosis induced by N-Smase.","date":"2006","source":"Glycoconjugate journal","url":"https://pubmed.ncbi.nlm.nih.gov/16691498","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25484313","id":"PMC_25484313","title":"Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25484313","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12244059","id":"PMC_12244059","title":"Structural requirements for selective binding of ISC1 to anionic phospholipids.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12244059","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21256847","id":"PMC_21256847","title":"Characterization of inositol phospho-sphingolipid-phospholipase C 1 (Isc1) in Cryptococcus neoformans reveals unique biochemical features.","date":"2011","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/21256847","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29679745","id":"PMC_29679745","title":"Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinent.","date":"2018","source":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29679745","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12820895","id":"PMC_12820895","title":"Functional analysis of ISC1 by site-directed mutagenesis.","date":"2003","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12820895","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12180980","id":"PMC_12180980","title":"ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance of Saccharomyces cerevisiae.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12180980","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19158081","id":"PMC_19158081","title":"Hydroxyurea sensitivity reveals a role for ISC1 in the regulation of G2/M.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19158081","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21840863","id":"PMC_21840863","title":"Cellular morphogenesis under stress is influenced by the sphingolipid pathway gene ISC1 and DNA integrity checkpoint genes in Saccharomyces cerevisiae.","date":"2011","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21840863","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37364689","id":"PMC_37364689","title":"Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.","date":"2023","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/37364689","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36377885","id":"PMC_36377885","title":"Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function.","date":"2022","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/36377885","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32205408","id":"PMC_32205408","title":"Yeast Sphingolipid Phospholipase Gene ISC1 Regulates the Spindle Checkpoint by a CDC55-Dependent Mechanism.","date":"2020","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32205408","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25398597","id":"PMC_25398597","title":"Differential modulation of S1PR(1-5) and specific activities of SphK and nSMase in pulmonary and cerebral tissues of rats exposed to hypobaric hypoxia.","date":"2014","source":"Lipids","url":"https://pubmed.ncbi.nlm.nih.gov/25398597","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41856059","id":"PMC_41856059","title":"In differentiated HL-60 neutrophil-like cells, MRP1- (ABCC1-) mediated glutathione efflux stimulated by BzATP and P2X7 receptor signalling regulates exosome release through nSMase activity.","date":"2026","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/41856059","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.31.667850","title":"Integrative immune subtyping of HNSCC reveals clinically relevant phenotypes and treatment-associated transitions","date":"2025-08-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.31.667850","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.26.640157","title":"Sphingolipid metabolism drives mitochondria remodeling during aging and oxidative stress","date":"2025-02-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.26.640157","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12676795","id":"PMC_12676795","title":"Trk receptors: roles in neuronal signal transduction.","date":"2003","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12676795","citation_count":2042,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18391951","id":"PMC_18391951","title":"Many sequence variants affecting diversity of adult human height.","date":"2008","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18391951","citation_count":520,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889548","id":"PMC_8889548","title":"Normalization and subtraction: two approaches to facilitate gene discovery.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889548","citation_count":401,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15013522","id":"PMC_15013522","title":"Ceramide synthesis and metabolism as a target for cancer therapy.","date":"2004","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/15013522","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9520418","id":"PMC_9520418","title":"Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling?","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9520418","citation_count":251,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15175033","id":"PMC_15175033","title":"Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis.","date":"2004","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/15175033","citation_count":236,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17207965","id":"PMC_17207965","title":"hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17207965","citation_count":222,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12566438","id":"PMC_12566438","title":"Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12566438","citation_count":170,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19913121","id":"PMC_19913121","title":"Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.","date":"2009","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19913121","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17449104","id":"PMC_17449104","title":"Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.","date":"2007","source":"Progress in lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/17449104","citation_count":140,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15051724","id":"PMC_15051724","title":"Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15051724","citation_count":139,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25168245","id":"PMC_25168245","title":"Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signaling.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/25168245","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18040843","id":"PMC_18040843","title":"Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis.","date":"2007","source":"Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18040843","citation_count":94,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15509740","id":"PMC_15509740","title":"Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15509740","citation_count":92,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10608884","id":"PMC_10608884","title":"Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608884","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32707033","id":"PMC_32707033","title":"Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases.","date":"2020","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/32707033","citation_count":88,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24981860","id":"PMC_24981860","title":"Human-chromatin-related protein interactions identify a demethylase complex required for chromosome segregation.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24981860","citation_count":80,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20836852","id":"PMC_20836852","title":"Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.","date":"2010","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20836852","citation_count":74,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20448054","id":"PMC_20448054","title":"Neutral sphingomyelinase 2: a novel target in cigarette smoke-induced apoptosis and lung injury.","date":"2010","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20448054","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24358176","id":"PMC_24358176","title":"Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24358176","citation_count":64,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12917,"output_tokens":422,"usd":0.022541},"stage2":{"model":"claude-opus-4-6","input_tokens":3581,"output_tokens":1399,"usd":0.07932},"total_usd":0.391096,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":27403,"output_tokens":7089,"usd":0.094272},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9475,"output_tokens":3304,"usd":0.194963}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"NSMase-2 (SMPD2) expressed in primary rat hepatocytes localizes to the plasma membrane, increases cellular ceramide levels, potentiates IL-1β-induced JNK phosphorylation, and this potentiation is mediated by a PP2A-family phosphatase, possibly by modulating phosphorylation of IL-1β receptor-associated kinase (IRAK).\",\n      \"method\": \"Adenovirus-mediated gene transfer of FLAG-tagged NSMase-2 into primary hepatocytes; immunofluorescence for localization; ceramide measurement; JNK phosphorylation assay; pharmacological inhibition of PP2A\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple functional readouts in primary cells with pharmacological pathway dissection, single lab\",\n      \"pmids\": [\"15059969\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"No mechanistic findings about the human/mammalian SMPD2 protein itself are robustly established in the available literature; the corpus is dominated by studies of the yeast ISC1 ortholog and a distinct murine mitochondria-associated neutral sphingomyelinase (MA-nSMase/SMPD5), with only one study (PMID:15059969) directly expressing and functionally characterizing NSMase-2 (SMPD2), showing it localizes to the plasma membrane, generates ceramide, and amplifies IL-1β-induced JNK activation via a PP2A-family phosphatase.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper before extracting discoveries.\n\n**Classification:**\n\n**Retrieved Papers:**\n1. ISC1 in yeast — KEEP (yeast ortholog of mammalian nSMase/SMPD2)\n2. MA-nSMase (SMPD5) — EXCLUDE (describes SMPD5, a paralog, not SMPD2)\n3. NSMase-2 in hepatocytes — KEEP (describes mouse nSMase-2/SMPD2)\n4. Isc1 in yeast mitochondria — KEEP (yeast ortholog)\n5. ISC1 diauxic shift — KEEP (yeast ortholog)\n6. ISC1 review — KEEP (yeast ortholog review)\n7. LacCer apoptosis/N-SMase deficient cells — EXCLUDE (uses an undefined mutant cell line, no direct SMPD2 mechanism)\n8. MA-nSMase localization — EXCLUDE (SMPD5, not SMPD2)\n9. ISC1 anionic phospholipid binding — KEEP (yeast ortholog)\n10. Cryptococcus Isc1 — EXCLUDE (fungal pathogen, symbol collision context — different organism, incompatible function profile)\n11. Leishmania ISC1 genomics — EXCLUDE (alias collision — ISC1 here is a Leishmania population name, not the gene)\n12. ISC1 site-directed mutagenesis — KEEP (yeast ortholog)\n13. ISC1 halotolerance — KEEP (yeast ortholog)\n14. ISC1 G2/M regulation — KEEP (yeast ortholog)\n15. ISC1 morphogenesis — KEEP (yeast ortholog)\n16. Chronic nSMase inhibition AD mice — EXCLUDE (pharmacological inhibition, no direct SMPD2 mechanism)\n17. Isc1 and Pgc1 cooperate — KEEP (yeast ortholog)\n18. ISC1 spindle checkpoint — KEEP (yeast ortholog)\n19. nSMase differential modulation hypoxia — EXCLUDE (expression/activity correlation only)\n20. MRP1/nSMase exosome release — EXCLUDE (no specific SMPD2 mechanism established)\n21. HNSCC immune subtypes ISC1-ISC4 — EXCLUDE (alias collision — ISC1 here is immune subtype cluster name)\n22. Sphingolipid metabolism mitochondria aging — KEEP (yeast ortholog, Isc1 overexpression functional result)\n\n**Gene2pubmed curated papers:**\n1. Trk receptors — EXCLUDE (no SMPD2 content)\n2. MGC cDNA — EXCLUDE (genomics resource)\n3. BioPlex — EXCLUDE (interactome resource, no specific SMPD2 mechanism)\n4. BioPlex 2.0 — EXCLUDE (interactome resource)\n5. HuRI — EXCLUDE (interactome resource)\n6. BioPlex 3.0 — EXCLUDE (interactome resource)\n7. GO phylogenetic propagation — EXCLUDE (bioinformatics)\n8. Height GWAS — EXCLUDE (GWAS)\n9. MGC expansion — EXCLUDE (genomics resource)\n10. Alternative promoters — EXCLUDE (genomics)\n11. Normalization/subtraction cDNA — EXCLUDE (genomics)\n12. BioID proximity map — EXCLUDE (proteomics resource)\n13. Ceramide synthesis cancer — EXCLUDE (review, no direct SMPD2 mechanism)\n14. Cloned mammalian nSMase (SMPD2) — KEEP (original cloning and characterization of SMPD2)\n15. HumanCVD lipids GWAS — EXCLUDE (GWAS)\n16. hORFeome — EXCLUDE (resource)\n17. Biochemical properties nSMase2 (SMPD2) — KEEP (direct biochemical characterization)\n18. Gene-centric lipid associations — EXCLUDE (GWAS)\n19. S1P and C1P metabolism review — EXCLUDE (review, no direct SMPD2 experiments)\n20. nSMase2 confluence growth arrest MCF7 — KEEP (SMPD2 direct functional study)\n21. nSMase1/SMPD2 phosphorylation by JNK — KEEP (direct SMPD2 mechanism — note: paper uses \"nSMase1\" for the zebrafish/vertebrate SMPD2 ortholog)\n22. Oxidative stress oligodendrocytes neutral SMase — EXCLUDE (antisense knockdown without specific SMPD2 identification)\n23. HIV gp120 neutral SMase neurons — EXCLUDE (antisense knockdown, nSMase not specifically identified as SMPD2)\n24. Cloned putative nSMase as lyso-PAF-PLC — KEEP (SMPD2 functional characterization — this is the original nSMase1 clone later shown to be lyso-PAF-PLC)\n25. Kinase interaction network — EXCLUDE (resource)\n26. Chromatin demethylase complex — EXCLUDE (no SMPD2 content)\n27. ND interactome — EXCLUDE (resource)\n28. Withanolide D nSMase2 apoptosis — KEEP (identifies SMPD2/nSMase2 as mediator with siRNA)\n29. nSMase2 cigarette smoke — KEEP (SMPD2 in vivo role established)\n30. Ceramide Ox-LDL VSMC calcification — EXCLUDE (uses GW4869 inhibitor only, no direct SMPD2 mechanism)\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"The cloned murine and human SMPD2 (then called nSMase) was identified as a ubiquitously expressed integral membrane protein with Mg2+-dependent neutral sphingomyelinase activity at the plasma membrane. Stable overexpression in U937 and HEK cells confirmed sphingomyelinase activity, though TNF-α stimulation produced only modest ceramide elevation without activating JNK, NFκB, or ERK1 pathways in these overexpressor lines.\",\n      \"method\": \"Molecular cloning, stable overexpression, in vitro SMase activity assays, signal transduction assays (JNK, NFκB, PARP cleavage)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — original cloning with in vitro activity characterization and functional overexpression, foundational paper\",\n      \"pmids\": [\"9520418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The originally cloned putative nSMase (SMPD2/nSMase1) was shown to function primarily as a lyso-platelet-activating factor phospholipase C (lyso-PAF-PLC) rather than as a sphingomyelinase in cells. Overexpression did not alter ceramide or sphingomyelin metabolism but caused accumulation of 1-O-alkyl-sn-glycerol, and in vitro assays demonstrated lyso-PAF and lyso-PC are substrates.\",\n      \"method\": \"Radiolabeling with [3H]palmitic acid/[3H]hexadecanol, in vitro substrate assays, immunoprecipitation of enzyme activity, metabolic labeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with substrate specificity testing and cellular metabolic tracing, rigorous functional reassignment\",\n      \"pmids\": [\"10608884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The yeast SMPD2 ortholog ISC1 (YER019w) was identified as an inositol phosphosphingolipid phospholipase C (IPS-PLC). Overexpression greatly increased neutral SMase activity in a phosphatidylserine-dependent manner; ISC1 deletion eliminated neutral SMase and IPS-PLC activities and caused accumulation of complex sphingolipids, establishing ISC1 as the first enzyme in complex sphingolipid catabolism in yeast.\",\n      \"method\": \"Overexpression, gene deletion, in vitro enzyme activity assays, [3H]dihydrosphingosine metabolic labeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic loss-of-function combined with in vitro activity assays and metabolic labeling, foundational paper with 134 citations\",\n      \"pmids\": [\"11006294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Structural determinants for ISC1 activation by anionic phospholipids were defined. The second transmembrane domain (TMII) and C-terminus are required and sufficient for binding phosphatidylserine (PS), cardiolipin (CL), and phosphatidylglycerol (PG). Positively charged residues at the C-terminus mediate PS/CL/PG interaction and enzyme activation. Reconstitution experiments showed that the N-terminal catalytic domain and C-terminal region must interact for enzymatic activity, suggesting PS pulls the catalytic domain to the membrane.\",\n      \"method\": \"Site-directed mutagenesis, deletion mutants, lipid-protein overlay assays, GFP fusion heterologous expression, enzymatic reconstitution from separate fragments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods including mutagenesis, lipid binding assays, and reconstitution\",\n      \"pmids\": [\"12244059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ISC1-encoded inositol phosphosphingolipid phospholipase C is involved in Na+/Li+ halotolerance in yeast. Deletion of ISC1 severely impaired growth on NaCl/LiCl, reduced Na+/Li+-stimulated ENA1 (cation-extrusion ATPase) expression, and decreased Ena1p-dependent ion extrusion, placing ISC1-dependent sphingolipid hydrolysis as an early event in salt-induced ENA1 signaling.\",\n      \"method\": \"Gene deletion, growth assays, ENA1-lacZ reporter assays, ion extrusion measurements\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with reporter assays, single lab\",\n      \"pmids\": [\"12180980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Catalytic residues of ISC1 were defined by site-directed mutagenesis: E100, N233, and H334 are essential for catalysis. A P-loop-like domain (G162–S169) was identified; D163A and K168A completely abolished activity, while G162A, G167A, and S169A reduced Vmax without affecting Km. The P-loop-like domain is involved in Mg2+ binding and optimal catalytic efficiency, potentially interacting with the PS activator.\",\n      \"method\": \"Site-directed mutagenesis, in vitro enzyme kinetics (Km, Vmax, Mg2+ Ka), phosphatidylserine binding assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — systematic active-site mutagenesis with kinetic characterization\",\n      \"pmids\": [\"12820895\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Mouse nSMase2 (SMPD2) was biochemically characterized as a bona fide neutral sphingomyelinase. The enzyme requires Mg2+, is activated by phosphatidylserine, and is inhibited by GW4869. Overexpression in MCF7 cells decreased sphingomyelin levels by 40% and increased ceramide by 60%. nSMase2 overexpression reduced cell growth by 30–40%, and TNF-α induced ~50% activation of nSMase2 in overexpressing MCF7 cells.\",\n      \"method\": \"Heterologous expression in isc1Δ yeast, in vitro activity assays, SM/ceramide mass measurement in MCF7 cells, [3H] labeling, cell growth assays, TNF-α stimulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution in isc1Δ yeast plus cellular SM/ceramide mass measurements with multiple orthogonal approaches\",\n      \"pmids\": [\"12566438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Endogenous nSMase2 (SMPD2) functions as a growth suppressor in MCF7 cells. At confluence, nSMase2 mRNA was upregulated ~5-fold, neutral SMase activity increased 119%, and ceramide (particularly very long chain C24:1 and C24:0 species) was elevated. siRNA knockdown of nSMase2 increased S-phase cells by 59%, prevented hypophosphorylation of retinoblastoma protein, and blocked p21(WAF1) induction. nSMase2 also redistributed from cytoplasm to plasma membrane upon confluence.\",\n      \"method\": \"siRNA knockdown, cell cycle analysis (flow cytometry), ceramide mass measurement, western blotting (Rb phosphorylation, p21), immunofluorescence localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with multiple downstream readouts (cell cycle, ceramide species, Rb/p21), confirmed localization change\",\n      \"pmids\": [\"15051724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Expression of FLAG-tagged mouse nSMase2 (SMPD2) in primary rat hepatocytes via adenoviral gene transfer increased cellular ceramide levels and potentiated IL-1β-induced JNK phosphorylation 1.5–2-fold. This potentiation was mediated by a PP2A family phosphatase, possibly by modulating IRAK phosphorylation. nSMase2 localized to the plasma membrane in HepG2 cells.\",\n      \"method\": \"Adenovirus-mediated gene transfer, in vitro SMase activity assay, ceramide measurement, JNK phosphorylation assay, phosphatase inhibitor studies, immunofluorescence\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with ceramide and JNK readouts, PP2A pathway placed mechanistically, single lab\",\n      \"pmids\": [\"15059969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Yeast Isc1p (SMPD2 ortholog) localizes to the outer mitochondrial membrane as an integral membrane protein in the post-diauxic phase. Endogenous Isc1p activity was enriched in highly purified mitochondria. Mitochondria from isc1Δ cells showed 93% loss of alpha-hydroxylated phytoceramide. Functionally, isc1Δ exhibited higher respiratory-deficient cell rates at high temperature and sensitivity to hydrogen peroxide, establishing mitochondrial ceramide generation by Isc1p as important for mitochondrial function.\",\n      \"method\": \"Subcellular fractionation, western blotting of mitochondrial fractions, LC/MS sphingolipid profiling, respiratory competence assays, oxidative stress sensitivity assays\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by fractionation combined with lipidomics and functional phenotypes, multiple orthogonal methods\",\n      \"pmids\": [\"17880915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ISC1 (SMPD2 ortholog) regulates the G2/M checkpoint in yeast. isc1Δ cells treated with hydroxyurea (HU) showed G2/M block associated with elevated Cdc28-Tyr19 phosphorylation. Sustained Swe1p (the kinase phosphorylating Cdc28-Tyr19) levels in isc1Δ cells after HU were responsible; deletion of SWE1 in isc1Δ overcame the G2/M block. A Cdc28-Y19F mutant also rescued isc1Δ from G2/M arrest, placing Isc1p as an upstream regulator of Swe1p stability.\",\n      \"method\": \"Flow cytometry cell cycle analysis, western blotting (Cdc28-pTyr19, Swe1p), double-mutant genetic epistasis (isc1Δ/swe1Δ, isc1Δ/cdc28-Y19F), HU sensitivity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double mutants and phosphorylation site mutants, multiple readouts\",\n      \"pmids\": [\"19158081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Isc1p (SMPD2 ortholog) in yeast mitochondria is required for metabolic adaptation during the diauxic shift. isc1Δ cells showed defective aerobic respiration despite intact intrinsic mitochondrial functions (normal mtDNA, O2 consumption, membrane potential). Microarray analysis revealed failure to upregulate genes for nonfermentable carbon metabolism. The mitochondrial requirement for this nuclear gene induction overlapped with Adr1p-, Snf1p-, and Cat8p-dependent genes, but did not activate the retrograde response.\",\n      \"method\": \"Microarray gene expression, respiratory assays, mitochondrial membrane potential measurement, mtDNA analysis, genetic analysis with petite cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide expression + mitochondrial function assays, single lab\",\n      \"pmids\": [\"19179331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"nSMase2 (SMPD2) was identified as a critical mediator of Withanolide D-induced apoptosis in leukemia cells. siRNA knockdown of nSMase2 and the nSMase inhibitor GW4869 significantly reduced ceramide generation, MKK4 and MKK3/6 phosphorylation, and apoptosis in K562 and MOLT-4 cells, placing SMPD2 upstream of the JNK/p38 MAPK cascade in this apoptotic pathway.\",\n      \"method\": \"siRNA knockdown of nSMase2, pharmacological inhibition (GW4869), ceramide measurement, kinase phosphorylation assays (JNK, p38, MKK4, MKK3/6), apoptosis assays\",\n      \"journal\": \"Molecular cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA loss-of-function with multiple downstream kinase readouts, single lab\",\n      \"pmids\": [\"20836852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"nSMase2 (SMPD2) was established as the central in vivo mediator of cigarette smoke-induced ceramide generation and apoptosis in lung. Heterozygous nSMase2 mice showed significantly decreased ceramide after CS exposure; aSMase knockout mice maintained wild-type ceramide levels. Anti-nSMase2 siRNA abrogated CS-induced ceramide elevation and TUNEL-positive cells. N-acetyl cysteine treatment also abrogated these effects, linking oxidative stress to nSMase2 activation.\",\n      \"method\": \"nSMase2 heterozygous mouse model, aSMase knockout mice, in vivo siRNA, ceramide measurement in lung tissue, TUNEL assay, N-acetyl cysteine treatment\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic models (heterozygous KO, siRNA) with multiple controls and orthogonal endpoints\",\n      \"pmids\": [\"20448054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ISC1 (SMPD2 ortholog) interacts with the DNA integrity checkpoint pathway to control cell morphology. isc1Δ cells under HU treatment exhibited morphological aberrations, cell-wall defects, and defects in actin depolymerization. Genetic analysis showed synthetic interactions: isc1Δ combined with mrc1Δ, tof1Δ, or csm3Δ enhanced morphological defects, while isc1Δ/rad9Δ reduced them. Swe1 and Cdk1 were identified as key mediators, and Rad53 dosage partially influenced isc1Δ morphology.\",\n      \"method\": \"Genetic epistasis (double mutants), flow cytometry, morphological analysis, actin staining, checkpoint gene deletions\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic genetic epistasis across multiple checkpoint genes, single lab\",\n      \"pmids\": [\"21840863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SMPD2 (nSMase1 in zebrafish nomenclature) is phosphorylated by JNK at Ser-270, which activates the enzyme to generate ceramide and induce apoptosis. S270A substitution blocked phosphorylation and activation; S270E (phosphomimetic) mimicked activation. JNK inhibitor SP600125 blocked nSMase1 phosphorylation and ceramide generation. Multiple stresses (heat shock, UV, H2O2, anti-Fas) induced this phosphorylation. MAPK8/9 or SMPD2 RNAi knockdown in human Jurkat T cells decreased ceramide and stress/cytokine-induced apoptosis.\",\n      \"method\": \"Site-directed mutagenesis (S270A, S270E), JNK inhibitor treatment, RNAi knockdown in zebrafish and human Jurkat cells, ceramide measurement, apoptosis assays, phosphorylation assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — phosphorylation site mutagenesis with phosphomimetic + loss-of-function in two cell systems, multiple stress stimuli tested\",\n      \"pmids\": [\"25168245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In yeast, ISC1 (SMPD2 ortholog) is positioned within the spindle assembly checkpoint (SAC) pathway. Deletion of SAC genes (BUB1, MAD1, BIM1, KAR3) phenocopied ISC1 deletion, and spindle checkpoint genes act upstream of Isc1. ISC1 deletion mutants were sensitive to benomyl (SAC defect indicator) and failed spindle elongation in HU-treated cells (similar to bub1Δ). PP2A-Cdc55 ceramide-activated phosphatase acts downstream of Isc1p, coupling the spindle checkpoint to CDC55-mediated nuclear functions.\",\n      \"method\": \"Synthetic lethality analysis, gene deletion, benomyl sensitivity assays, spindle elongation imaging, epistasis with cdc55, concordance analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — synthetic lethality combined with epistasis and functional assays, single lab\",\n      \"pmids\": [\"32205408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In yeast, Isc1 (SMPD2 ortholog) and the PG-specific phospholipase Pgc1 functionally cooperate to regulate mitochondrial function. Deletion of PGC1 rescued the mitochondrial dysfunction (reduced PE levels and cytochrome c oxidase activity) in isc1Δ cells. The Pgc1 substrate PG inhibited Isc1 activity in vitro. Products of Isc1-mediated hydrolysis partially inhibited Pgc1 activity, establishing a cross-inhibitory feedback loop linking sphingolipid and phospholipid metabolism for mitochondrial homeostasis.\",\n      \"method\": \"Double-mutant genetic rescue (pgc1Δ isc1Δ), in vitro enzyme activity assays with PG substrate/inhibitor, PE and cytochrome c oxidase activity measurements\",\n      \"journal\": \"Microbiology spectrum\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic rescue combined with in vitro enzyme assays, single lab\",\n      \"pmids\": [\"36377885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Overexpression of Isc1 (SMPD2 ortholog) in chronologically aged yeast prevented dramatic mitochondrial morphological changes (large rounded morphology, decreased outer membrane/matrix co-localization, decreased membrane potential) that normally occur during aging. Similar sphingolipid-dependent mitochondrial morphological transitions were observed following acute oxidative stress, suggesting SMPD2-ortholog activity promotes adaptive mitochondrial remodeling.\",\n      \"method\": \"Isc1 overexpression, confocal microscopy of mitochondrial morphology, pharmacological and genetic perturbation of sphingolipid biosynthesis, mitochondrial membrane potential measurements\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, single lab, morphological readout without full mechanistic dissection\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SMPD2 (neutral sphingomyelinase 2/nSMase2) is a Mg2+-dependent integral membrane neutral sphingomyelinase that hydrolyzes sphingomyelin to ceramide and phosphocholine at the plasma membrane; its catalytic activity requires conserved residues E100, N233, H334, and a P-loop-like domain (D163, K168) involved in Mg2+ coordination, while activation depends on anionic phospholipids (phosphatidylserine, cardiolipin) binding to the second transmembrane domain and C-terminus; in cells, SMPD2 is activated by TNF-α, JNK-mediated phosphorylation at Ser-270, and oxidative/genotoxic stress to generate ceramide that drives G0/G1 arrest (via Rb hypophosphorylation and p21 induction), apoptosis (via JNK/p38 MAPK cascades), and — through its yeast ortholog Isc1p — regulates the G2/M and spindle checkpoints via Swe1p stability and PP2A-Cdc55 ceramide-activated phosphatase, and localizes to mitochondria to support mitochondrial lipid homeostasis and metabolic adaptation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SMPD2 (NSMase-2) is a neutral sphingomyelinase that localizes to the plasma membrane, where it hydrolyzes sphingomyelin to generate ceramide [PMID:15059969]. In primary rat hepatocytes, SMPD2 overexpression elevates cellular ceramide and potentiates IL-1β-induced JNK phosphorylation through a mechanism dependent on a PP2A-family phosphatase, linking sphingolipid metabolism to inflammatory signaling [PMID:15059969].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that SMPD2 is a plasma-membrane-localized sphingomyelinase that couples ceramide generation to amplification of IL-1β/JNK signaling via PP2A-family phosphatase activity answered whether this enzyme has a direct role in cytokine signal transduction.\",\n      \"evidence\": \"Adenoviral overexpression of FLAG-tagged NSMase-2 in primary rat hepatocytes with immunofluorescence, ceramide quantification, JNK phosphorylation assays, and PP2A pharmacological inhibition\",\n      \"pmids\": [\"15059969\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding without independent replication\",\n        \"Endogenous SMPD2 loss-of-function (knockout or knockdown) has not been tested in this signaling context\",\n        \"Identity of the specific PP2A complex mediating JNK potentiation is not defined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological substrates, tissue-specific roles, and broader signaling functions of endogenous SMPD2 in mammalian cells remain uncharacterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genetic loss-of-function studies in mammalian systems\",\n        \"No structural or enzymological characterization of the human protein\",\n        \"Relationship to other neutral sphingomyelinases (e.g., SMPD3) in ceramide signaling is undefined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\nWait, I need to double-check the pathway term_id. Let me correct:\n\n```json\n{\n  \"mechanistic_narrative\": \"SMPD2 (NSMase-2) is a neutral sphingomyelinase that localizes to the plasma membrane, where it hydrolyzes sphingomyelin to generate ceramide [PMID:15059969]. In primary rat hepatocytes, SMPD2 overexpression elevates cellular ceramide and potentiates IL-1β-induced JNK phosphorylation through a mechanism dependent on a PP2A-family phosphatase, linking sphingolipid metabolism to inflammatory signaling [PMID:15059969].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing that SMPD2 is a plasma-membrane-localized sphingomyelinase that couples ceramide generation to amplification of IL-1β/JNK signaling via PP2A-family phosphatase activity answered whether this enzyme has a direct role in cytokine signal transduction.\",\n      \"evidence\": \"Adenoviral overexpression of FLAG-tagged NSMase-2 in primary rat hepatocytes with immunofluorescence, ceramide quantification, JNK phosphorylation assays, and PP2A pharmacological inhibition\",\n      \"pmids\": [\"15059969\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding without independent replication\",\n        \"Endogenous SMPD2 loss-of-function (knockout or knockdown) has not been tested in this signaling context\",\n        \"Identity of the specific PP2A complex mediating JNK potentiation is not defined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The physiological substrates, tissue-specific roles, and broader signaling functions of endogenous SMPD2 in mammalian cells remain uncharacterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genetic loss-of-function studies in mammalian systems\",\n        \"No structural or enzymological characterization of the human protein\",\n        \"Relationship to other neutral sphingomyelinases (e.g., SMPD3) in ceramide signaling is undefined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SMPD2 encodes a Mg²⁺-dependent neutral sphingomyelinase that hydrolyzes sphingomyelin to ceramide and phosphocholine, functioning as a stress-responsive ceramide generator that couples lipid signaling to cell cycle arrest, apoptosis, and mitochondrial homeostasis. Catalysis requires conserved residues E100, N233, H334, and a P-loop-like domain (D163, K168) involved in Mg²⁺ coordination, and the enzyme is activated by anionic phospholipids (phosphatidylserine, cardiolipin) binding to its second transmembrane domain and C-terminus [PMID:12820895, PMID:12244059]. JNK-mediated phosphorylation at Ser-270 activates SMPD2 under diverse stresses (UV, oxidative stress, TNF-α, anti-Fas), and the resulting ceramide drives G0/G1 arrest through Rb hypophosphorylation and p21 induction, or apoptosis via JNK/p38 MAPK cascades [PMID:25168245, PMID:15051724, PMID:20836852]. Studies of the yeast ortholog Isc1p further establish roles in mitochondrial ceramide generation critical for respiratory adaptation, mitochondrial morphology maintenance, and integration with checkpoint signaling through Swe1p stability and PP2A-Cdc55 [PMID:17880915, PMID:19158081, PMID:32205408].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Molecular cloning established SMPD2 as a ubiquitously expressed, Mg²⁺-dependent integral membrane neutral sphingomyelinase, resolving the molecular identity of a long-sought mammalian nSMase activity.\",\n      \"evidence\": \"Cloning and stable overexpression in U937 and HEK cells with in vitro SMase activity assays\",\n      \"pmids\": [\"9520418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Overexpression did not robustly activate JNK/NFκB, leaving signaling function uncertain\", \"Endogenous loss-of-function data were lacking\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"A functional reassignment revealed that overexpressed SMPD2 acts primarily as a lyso-PAF phospholipase C in cellular contexts, raising questions about whether sphingomyelin is its physiological substrate in vivo.\",\n      \"evidence\": \"Metabolic labeling with [³H]palmitic acid and in vitro substrate specificity assays in overexpressing cells\",\n      \"pmids\": [\"10608884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Controversy about primary substrate identity not fully resolved for endogenous enzyme\", \"Lyso-PAF PLC activity not tested in all relevant cell types\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of the yeast ortholog ISC1 as an inositol phosphosphingolipid phospholipase C that accounts for all neutral SMase activity in yeast provided genetic tractability and confirmed sphingolipid hydrolysis as the conserved core function.\",\n      \"evidence\": \"Gene deletion eliminating neutral SMase/IPS-PLC activity, metabolic labeling showing sphingolipid accumulation in isc1Δ\",\n      \"pmids\": [\"11006294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Yeast sphingolipid substrates differ from mammalian sphingomyelin\", \"Whether mammalian SMPD2 performs equivalent in vivo sphingomyelin hydrolysis remained unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Structural dissection of ISC1 revealed that anionic phospholipid activation requires the second transmembrane domain and C-terminal positively charged residues, and that the N-terminal catalytic domain must be recruited to the membrane by PS for activity.\",\n      \"evidence\": \"Site-directed mutagenesis, lipid-protein overlay assays, reconstitution from separate enzyme fragments\",\n      \"pmids\": [\"12244059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal structure to confirm membrane-recruitment model\", \"Mammalian SMPD2 C-terminal domain not independently tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Systematic active-site mutagenesis identified essential catalytic residues (E100, N233, H334) and a P-loop-like domain (D163, K168) required for Mg²⁺ coordination, defining the catalytic mechanism.\",\n      \"evidence\": \"Site-directed mutagenesis of ISC1 with full enzyme kinetics (Km, Vmax, Mg²⁺ Ka)\",\n      \"pmids\": [\"12820895\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural data confirming Mg²⁺ coordination geometry\", \"Applicability of all residue assignments to mammalian SMPD2 inferred by homology\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Biochemical characterization of mouse nSMase2 confirmed it as a bona fide neutral sphingomyelinase that reduces cellular sphingomyelin, elevates ceramide, suppresses growth, and is activated by TNF-α, resolving the substrate identity debate for the mammalian enzyme.\",\n      \"evidence\": \"Expression in isc1Δ yeast, SM/ceramide mass measurements in MCF7 cells, TNF-α stimulation\",\n      \"pmids\": [\"12566438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous loss-of-function data for mammalian SMPD2 not yet available\", \"Relative contribution of lyso-PAF PLC vs. SMase activity in vivo still unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Endogenous SMPD2 was shown to function as a growth suppressor that generates C24 ceramide species at confluence, enforcing G0/G1 arrest via Rb hypophosphorylation and p21 induction, and redistributes to the plasma membrane upon cell–cell contact.\",\n      \"evidence\": \"siRNA knockdown in MCF7 cells with flow cytometry, ceramide species analysis, Rb/p21 western blotting, immunofluorescence\",\n      \"pmids\": [\"15051724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of confluence-triggered SMPD2 upregulation unknown\", \"Direct link between C24 ceramide species and Rb/p21 pathway not established\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Isc1p was found to localize to the outer mitochondrial membrane during the post-diauxic phase, where it generates α-hydroxylated phytoceramide essential for mitochondrial function under stress, establishing a mitochondrial role for this enzyme family.\",\n      \"evidence\": \"Subcellular fractionation of purified mitochondria, LC/MS sphingolipidomics, respiratory competence and oxidative stress assays in isc1Δ\",\n      \"pmids\": [\"17880915\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian SMPD2 also translocates to mitochondria is unknown\", \"Mechanism of Isc1p mitochondrial targeting not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"ISC1 was positioned as a regulator of the G2/M checkpoint through control of Swe1p stability and Cdc28-Tyr19 phosphorylation, and as necessary for metabolic gene reprogramming during the diauxic shift, broadening its role beyond lipid metabolism to cell cycle and metabolic adaptation.\",\n      \"evidence\": \"Double-mutant epistasis (isc1Δ/swe1Δ, Cdc28-Y19F), flow cytometry, microarray gene expression profiling\",\n      \"pmids\": [\"19158081\", \"19179331\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling intermediates between ceramide and Swe1p stabilization not identified\", \"Transcriptional regulation mechanism downstream of mitochondrial ceramide unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"SMPD2 was validated as the central in vivo mediator of stress-induced ceramide generation and apoptosis, shown in cigarette smoke-exposed mouse lung (heterozygous KO) and in leukemia cells where it acts upstream of MKK4–JNK/p38 MAPK cascades.\",\n      \"evidence\": \"nSMase2 heterozygous mice, in vivo siRNA, aSMase KO controls, siRNA and GW4869 in leukemia cell lines with kinase phosphorylation readouts\",\n      \"pmids\": [\"20448054\", \"20836852\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full knockout mouse phenotype not reported\", \"Tissue-specific contributions of SMPD2 vs. SMPD3 not delineated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"JNK-mediated phosphorylation at Ser-270 was identified as the activating post-translational modification of SMPD2, explaining how diverse stresses converge on ceramide generation and apoptosis.\",\n      \"evidence\": \"S270A/S270E mutagenesis, JNK inhibitor, RNAi in zebrafish and Jurkat cells, multiple stress stimuli\",\n      \"pmids\": [\"25168245\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how S270 phosphorylation increases catalytic activity unknown\", \"Other potential phosphorylation sites not systematically mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"ISC1 was integrated into the spindle assembly checkpoint pathway, with SAC genes acting upstream and PP2A-Cdc55 acting as a ceramide-activated phosphatase downstream, linking sphingolipid signaling to mitotic fidelity.\",\n      \"evidence\": \"Synthetic lethality with SAC gene deletions, benomyl sensitivity, epistasis with CDC55\",\n      \"pmids\": [\"32205408\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct biochemical activation of PP2A-Cdc55 by ceramide species not shown\", \"Mammalian counterpart of this checkpoint connection not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A cross-inhibitory feedback loop between Isc1 and the phospholipase Pgc1 was discovered, integrating sphingolipid and phospholipid metabolism for mitochondrial homeostasis.\",\n      \"evidence\": \"Double-mutant rescue (pgc1Δ isc1Δ), in vitro enzyme inhibition assays, PE and cytochrome c oxidase measurements\",\n      \"pmids\": [\"36377885\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative flux through this feedback loop in vivo not measured\", \"Mammalian equivalent of Pgc1 counterpart not identified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of SMPD2 catalysis and membrane association, the in vivo partitioning between SMase and lyso-PAF PLC activities, whether mammalian SMPD2 translocates to mitochondria, and the full phenotype of a complete SMPD2 knockout mouse.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure available\", \"Complete SMPD2 knockout mouse not characterized\", \"Relative physiological importance of lyso-PAF PLC vs. SMase activity unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 2, 5, 6]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7, 8]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:1430728\", \"supporting_discovery_ids\": [0, 2, 5, 6, 7, 17]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12, 13, 15]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7, 10, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [8, 12, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MAPK8\",\n      \"MAPK9\",\n      \"PP2A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}